These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension-a long-term retrospective multicenter trial. Sonnweber T; Tymoszuk P; Steringer-Mascherbauer R; Sigmund E; Porod-Schneiderbauer S; Kohlbacher L; Theurl I; Lang I; Weiss G; Löffler-Ragg J BMC Pulm Med; 2023 Apr; 23(1):143. PubMed ID: 37098543 [TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of a predictive algorithm for unsatisfactory response among patients with pulmonary arterial hypertension using health insurance claims data. Gauthier-Loiselle M; Tsang Y; Lefebvre P; Agron P; Royer J; Bell Lynum KS; Bennett L; Panjabi S Curr Med Res Opin; 2022 Jun; 38(6):1019-1030. PubMed ID: 35243952 [TBL] [Abstract][Full Text] [Related]
7. Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension. Zelt JGE; Hossain A; Sun LY; Mehta S; Chandy G; Davies RA; Contreras-Dominguez V; Dunne R; Doyle-Cox C; Wells G; Stewart DJ; Mielniczuk LM J Heart Lung Transplant; 2020 Jul; 39(7):675-685. PubMed ID: 32336606 [TBL] [Abstract][Full Text] [Related]
8. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation. Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338 [TBL] [Abstract][Full Text] [Related]
9. Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension. Brusca SB; Elinoff JM; Zou Y; Jang MK; Kong H; Demirkale CY; Sun J; Seifuddin F; Pirooznia M; Valantine HA; Tanba C; Chaturvedi A; Graninger GM; Harper B; Chen LY; Cole J; Kanwar M; Benza RL; Preston IR; Agbor-Enoh S; Solomon MA Circulation; 2022 Oct; 146(14):1033-1045. PubMed ID: 36004627 [TBL] [Abstract][Full Text] [Related]
10. Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort. Anderson JJ; Lau EM; Lavender M; Benza R; Celermajer DS; Collins N; Corrigan C; Dwyer N; Feenstra J; Horrigan M; Keating D; Kermeen F; Kotlyar E; McWilliams T; Rhodes B; Steele P; Thakkar V; Williams T; Whitford H; Whyte K; Weintraub R; Wrobel JP; Keogh A; Strange G Chest; 2020 Jan; 157(1):162-172. PubMed ID: 31563497 [TBL] [Abstract][Full Text] [Related]
11. Cytokines as prognostic biomarkers in pulmonary arterial hypertension. Boucly A; Tu L; Guignabert C; Rhodes C; De Groote P; Prévot G; Bergot E; Bourdin A; Beurnier A; Roche A; Jevnikar M; Jaïs X; Montani D; Wilkins MR; Humbert M; Sitbon O; Savale L Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36549710 [TBL] [Abstract][Full Text] [Related]
13. An algorithm to identify cases of pulmonary arterial hypertension from the electronic medical record. Schuler KP; Hemnes AR; Annis J; Farber-Eger E; Lowery BD; Halliday SJ; Brittain EL Respir Res; 2022 May; 23(1):138. PubMed ID: 35643554 [TBL] [Abstract][Full Text] [Related]
14. A framework of deep learning networks provides expert-level accuracy for the detection and prognostication of pulmonary arterial hypertension. Diller GP; Benesch Vidal ML; Kempny A; Kubota K; Li W; Dimopoulos K; Arvanitaki A; Lammers AE; Wort SJ; Baumgartner H; Orwat S; Gatzoulis MA Eur Heart J Cardiovasc Imaging; 2022 Oct; 23(11):1447-1456. PubMed ID: 35900292 [TBL] [Abstract][Full Text] [Related]
15. Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency. Sweatt AJ; Miyagawa K; Rhodes CJ; Taylor S; Del Rosario PA; Hsi A; Haddad F; Spiekerkoetter E; Bental-Roof M; Bland RD; Swietlik EM; Gräf S; Wilkins MR; Morrell NW; Nicolls MR; Rabinovitch M; Zamanian RT Chest; 2021 Oct; 160(4):1442-1458. PubMed ID: 34181952 [TBL] [Abstract][Full Text] [Related]
16. A multicenter random forest model for effective prognosis prediction in collaborative clinical research network. Li J; Tian Y; Zhu Y; Zhou T; Li J; Ding K; Li J Artif Intell Med; 2020 Mar; 103():101814. PubMed ID: 32143809 [TBL] [Abstract][Full Text] [Related]
17. Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases. Bertsimas D; Margonis GA; Sujichantararat S; Boerner T; Ma Y; Wang J; Kamphues C; Sasaki K; Tang S; Gagniere J; Dupré A; Løes IM; Wagner D; Stasinos G; Macher-Beer A; Burkhart R; Morioka D; Imai K; Ardiles V; O'Connor JM; Pawlik TM; Poultsides G; Seeliger H; Beyer K; Kaczirek K; Kornprat P; Aucejo FN; de Santibañes E; Baba H; Endo I; Lønning PE; Kreis ME; Weiss MJ; Wolfgang CL; D'Angelica M JAMA Surg; 2022 Aug; 157(8):e221819. PubMed ID: 35648428 [TBL] [Abstract][Full Text] [Related]
18. Plasma markers in pulmonary hypertension subgroups correlate with patient survival. Koudstaal T; van Uden D; van Hulst JAC; Heukels P; Bergen IM; Geenen LW; Baggen VJM; van den Bosch AE; van den Toorn LM; Chandoesing PP; Kool M; Boersma E; Hendriks RW; Boomars KA Respir Res; 2021 May; 22(1):137. PubMed ID: 33947407 [TBL] [Abstract][Full Text] [Related]
19. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction? Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466 [TBL] [Abstract][Full Text] [Related]